These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 23899639)
1. Intravenous abuse of methylphenidate. Imbert B; Cohen J; Simon N J Clin Psychopharmacol; 2013 Oct; 33(5):720-1. PubMed ID: 23899639 [No Abstract] [Full Text] [Related]
2. [Acute psychiatric symptoms during methylphenidate intravenous injections: A case report]. Vérité F; Micallef J Therapie; 2017 Jun; 72(3):367-372. PubMed ID: 27988038 [TBL] [Abstract][Full Text] [Related]
3. Ritalin: drug of abuse. Two case reports of intra-arterial injection. Still A; Gordon M; Mercer J; Roake J N Z Med J; 2001 Nov; 114(1144):521-2. PubMed ID: 11795565 [No Abstract] [Full Text] [Related]
4. Impact of withdrawal of Ritalin LA in the Western Cape. Donker Fv; Riordan G; Wilmshurst J S Afr Med J; 2008 Aug; 98(8):570. PubMed ID: 18928026 [No Abstract] [Full Text] [Related]
5. Necrotising myositis after intravenous methylphenidat (Ritalin) injection. Gautschi OP; Zellweger R Emerg Med J; 2006 Sep; 23(9):739. PubMed ID: 16921101 [No Abstract] [Full Text] [Related]
7. Dystonia in Methylphenidate Withdrawal: A Case Report. Grau-López L; Daigre C; Mercado N; Casas M; Roncero C J Addict Med; 2017; 11(2):154-156. PubMed ID: 27926589 [TBL] [Abstract][Full Text] [Related]
8. Painful Muscle Cramps Possibly Associated with Withdrawal from Methylphenidate. Coskun M; Kaya I J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):658-9. PubMed ID: 26132330 [No Abstract] [Full Text] [Related]
9. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders]. Aanonsen NO Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094 [TBL] [Abstract][Full Text] [Related]
10. [Ekbom syndrome in an intravenous methylphenidate abuser]. Pereiro Gómez C; Vicente-Alba J; Ramos-Caneda A; Vázquez Ventoso C; Fontela-Vivanco E; Díaz del Valle JC Adicciones; 2012; 24(4):301-7. PubMed ID: 23241717 [TBL] [Abstract][Full Text] [Related]
11. Successful lung transplantation for talcosis secondary to intravenous abuse of oral drug. Shlomi D; Shitrit D; Bendayan D; Sahar G; Shechtman Y; Kramer MR Int J Chron Obstruct Pulmon Dis; 2008; 3(2):327-30. PubMed ID: 18686743 [TBL] [Abstract][Full Text] [Related]
13. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. Kollins SH J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325 [TBL] [Abstract][Full Text] [Related]
15. Addictiveness of central stimulants. Dackis CA; Gold MS Adv Alcohol Subst Abuse; 1990; 9(1-2):9-26. PubMed ID: 1974121 [TBL] [Abstract][Full Text] [Related]
16. Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. Meririnne E; Kankaanpää A; Seppälä T J Pharmacol Exp Ther; 2001 Aug; 298(2):539-50. PubMed ID: 11454915 [TBL] [Abstract][Full Text] [Related]
18. [Infantile psychosis secondary to methylphenidate]. Fernández-Fernández MA; Rufo-Campos M; Mateos-Checa R; Muñoz-Cabello B; Madruga-Garrido M; Blanco-Martínez B Rev Neurol; 2011 Apr; 52(7):446-7. PubMed ID: 21425116 [No Abstract] [Full Text] [Related]
19. Methylphenidate in stimulants abuse: three case reports. Martínez-Cano H; Martínez-Gras I; De Iceta M; Rodao JM; Vela-Bueno A Am J Addict; 2001; 10(2):192-3. PubMed ID: 11444161 [No Abstract] [Full Text] [Related]